About Seqens
Seqens is a company based in Ecully (France) founded in 2003 was acquired by SK Capital in December 2021.. The company has 39 employees as of April 07, 2024. Seqens has completed 2 acquisitions, including CELLforCURE and CU Chemie Uetikon. Seqens offers products and services including APIs and Intermediates, Personal Care Ingredients, and Custom Specialty Ingredients. Seqens operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
- Headquarter Ecully, France
- Employees 39 as on 07 Apr, 2024
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Monolom India Pharma Private Limited
- Date of Incorporation 27 Oct, 2017
- Jurisdiction Pune, Maharashtra, India
-
Annual Revenue
$1.87 M (USD)19.92as on Mar 31, 2022
-
Net Profit
$183.32 K (USD)21.7as on Mar 31, 2022
-
EBITDA
$551.88 K (USD)1.58as on Mar 31, 2022
-
Latest Funding Round
-
Investors
Eurazeo
& 4 more
-
Employee Count
39
as on Apr 07, 2024
-
Investments & Acquisitions
CELLforCURE
& 1 more
-
Acquired by
SK Capital
(Dec 17, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Seqens
Seqens offers a comprehensive portfolio of products and services, including APIs and Intermediates, Personal Care Ingredients, and Custom Specialty Ingredients. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Manufacture generic and custom active pharmaceutical ingredients for industry use.
Wide range of ingredients for personal care market applications.
High-quality specialized chemical products for various applications.
Unlock access to complete
Funding Insights of Seqens
- Total Funding Total Funding
- Total Rounds 3
- Last Round Last Round
- First Round First Round
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2017 | Amount | Series A - Seqens | Valuation | Societe Generale Capital Partenaire |
|
| Jun, 2016 | Amount | Series A - Seqens | Valuation | Merieux Developement , Ardian |
|
| Jun, 2016 | Amount | Series A - Seqens | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Seqens
Seqens has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Eurazeo, Societe Generale Capital Partenaire and Merieux Developement. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are managed by Societe Generale Capital Partenaire.
|
Founded Year | Domain | Location | |
|
Private equity and debt investments are managed across multiple sectors.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Seqens
Seqens has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include CELLforCURE and CU Chemie Uetikon. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Develops innovative technologies for cell and gene therapy products to advance medical treatments.
|
2010 | ||||
|
Organic chemicals and pharmaceutical APIs are manufactured and distributed.
|
1970 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Seqens
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Seqens Comparisons
Competitors of Seqens
Seqens operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| domain | founded_year | HQ Location |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
|
| domain | founded_year | HQ Location |
APIs and enzymes are manufactured through fermentation by the CDMO.
|
|
| domain | founded_year | HQ Location |
APIs and finished products are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| domain | founded_year | HQ Location |
APIs and peptides are developed and manufactured by Asymchem.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Seqens
Frequently Asked Questions about Seqens
When was Seqens founded?
Seqens was founded in 2003 and raised its 1st funding round 13 years after it was founded.
Where is Seqens located?
Seqens is headquartered in Ecully, France. It is registered at Ecully, Auvergne-rhone-alpes, France.
How many employees does Seqens have?
As of Apr 07, 2024, the latest employee count at Seqens is 39.
What is the annual revenue of Seqens?
Annual revenue of Seqens is $1.87M as on Mar 31, 2022.
What does Seqens do?
Seqens was established in 2003 in Ecully, France, as a provider of contract manufacturing services within the pharmaceutical and chemical sectors. Operations focus on the production of small molecules and peptides for clients seeking outsourced manufacturing solutions. Services encompass development, scale-up, and commercial production, with facilities supporting global supply chains. The company operates primarily from European locations, emphasizing regulatory compliance and quality standards in its processes.
Who are the top competitors of Seqens?
Seqens's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.
What products or services does Seqens offer?
Seqens offers APIs and Intermediates, Personal Care Ingredients, and Custom Specialty Ingredients.
How many acquisitions has Seqens made?
Seqens has made 2 acquisitions, including CELLforCURE, and CU Chemie Uetikon.
Who are Seqens's investors?
Seqens has 5 investors. Key investors include Eurazeo, Societe Generale Capital Partenaire, Merieux Developement, Ardian, and SK Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.